Orders over $79.00 will receive free shipping. This is a residential delivery service, deliveries Monday through Friday from 9:00am to 8:00pm.Learn More
Unfortunately, we no longer carry this item. It may be discontinued or have just sold out.
Please contact Customer Service (1-888-676-8853) or search for another product if you continue to see this message.
Find other: Answer Helmet Offroads
Driven by a passion for creating a higher standard, the AR-5 helmet by Answer Racing brings an unparalleled step forward in safety and value. Never before has a fiberglass helmet been equipped with MIPS technology at such an affordable price. Developed by brain surgeons and scientists to reduce forces on the brain, MIPS has revolutionized the way we think about helmet safety. By adding a low-friction layer between the helmet and head, MIPS helps to reduce rotational forces on the brain that can occur during angled impacts to the head. A refined interior features Cool-Core technology that aids in evaporative cooling, a dual-density EPS liner that offers superior impact absorption and removable / washable cheek pads and helmet liner.
MIPS is an advanced and efficient brain protection system that provides a secure environment for riders of all kinds. MIPS industry-leading technology deals with "rotational violence" which is found to be the leading cause of concussion and even more severe brain injuries. It mimics the brain's own protection system.
When the head hits the ground at an angle, the brain slides along a membrane on the inner surface of the skull, which reduces the rotational forces transmitted to the brain. The MIPS yellow Low Friction Layer (LFL) sits between the helmet's EPS and the liner. At impact there is a movement, independent of direction, between MIPS and the liner that substantially reduces the rotational force to the brain.
MIPS does not interfere with a helmet's existing safety property, performance or design, adding minimal weight and less than 1 mm in thickness. It's based on more than 15 years of R&D at the Royal Institute of Technology and The Karolinska University Hospital in Stockholm, Sweden.